DK3773715T3 - Mirikizumab i behandlingen af colitis ulcerosa - Google Patents
Mirikizumab i behandlingen af colitis ulcerosa Download PDFInfo
- Publication number
- DK3773715T3 DK3773715T3 DK19722256.5T DK19722256T DK3773715T3 DK 3773715 T3 DK3773715 T3 DK 3773715T3 DK 19722256 T DK19722256 T DK 19722256T DK 3773715 T3 DK3773715 T3 DK 3773715T3
- Authority
- DK
- Denmark
- Prior art keywords
- mirikizumab
- treatment
- ulcerative colitis
- ulcerative
- colitis
- Prior art date
Links
- 206010009900 Colitis ulcerative Diseases 0.000 title 1
- 201000006704 Ulcerative Colitis Diseases 0.000 title 1
- 229950009792 mirikizumab Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862650314P | 2018-03-30 | 2018-03-30 | |
| PCT/US2019/024633 WO2019191464A1 (fr) | 2018-03-30 | 2019-03-28 | Méthodes de traitement de la colite ulcéreuse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3773715T3 true DK3773715T3 (da) | 2024-05-27 |
Family
ID=66429483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19722256.5T DK3773715T3 (da) | 2018-03-30 | 2019-03-28 | Mirikizumab i behandlingen af colitis ulcerosa |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20210032325A1 (fr) |
| EP (2) | EP4327866A3 (fr) |
| JP (3) | JP7119114B2 (fr) |
| KR (1) | KR102552693B1 (fr) |
| CN (1) | CN111936165A (fr) |
| AU (2) | AU2019243283C1 (fr) |
| BR (1) | BR112020018099A2 (fr) |
| CA (1) | CA3095297A1 (fr) |
| DK (1) | DK3773715T3 (fr) |
| EA (1) | EA202091989A1 (fr) |
| FI (1) | FI3773715T3 (fr) |
| IL (1) | IL277514A (fr) |
| LT (1) | LT3773715T (fr) |
| MA (1) | MA52216A (fr) |
| MX (1) | MX2020010269A (fr) |
| PT (1) | PT3773715T (fr) |
| SG (1) | SG11202009526RA (fr) |
| TW (1) | TWI744617B (fr) |
| WO (1) | WO2019191464A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021023295A2 (pt) | 2019-05-23 | 2022-02-08 | Janssen Biotech Inc | Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa |
| IL295545A (en) * | 2020-02-14 | 2022-10-01 | Janssen Biotech Inc | A safe and effective method for the treatment of ulcerative colitis with an anti-il-12/il23 antibody |
| WO2022085739A1 (fr) * | 2020-10-20 | 2022-04-28 | 協和化学工業株式会社 | Dispositif de gestion d'essais cliniques, procédé de gestion d'essais cliniques, programme de gestion d'essais cliniques et système de gestion d'essais cliniques |
| US20220259301A1 (en) * | 2021-01-06 | 2022-08-18 | Abbvie Inc. | Methods of treating crohn's disease and ulcerative colitis |
| KR20240012469A (ko) * | 2021-05-20 | 2024-01-29 | 얀센 바이오테크 인코포레이티드 | Il-23 및 tnf 알파에 대한 항체의 병용요법으로 염증성 장질환을 치료하는 방법 |
| EP4347018A1 (fr) * | 2021-05-28 | 2024-04-10 | Eli Lilly and Company | Régulation d'anticorps anti-il-23p19 de gènes impliqués dans la rectocolite hémorragique |
| US20240199734A1 (en) * | 2022-11-22 | 2024-06-20 | Janssen Biotech, Inc. | Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007005955A2 (fr) * | 2005-06-30 | 2007-01-11 | Centocor, Inc. | Anticorps anti-il-23, compositions, methodes et utilisations |
| SI3219328T1 (sl) | 2005-12-29 | 2020-10-30 | Janssen Biotech, Inc. | Človeška protitelesa proti-IL-23, sestavki, postopki in uporabe |
| AU2008218968B2 (en) | 2007-02-23 | 2013-10-17 | Merck Sharp & Dohme Llc | Engineered anti-IL-23p19 antibodies |
| WO2010062663A1 (fr) * | 2008-11-03 | 2010-06-03 | Schering Corporation | Biomarqueurs de maladie inflammatoire de l'intestin et procédés apparentés du traitement |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| NZ610592A (en) * | 2010-11-04 | 2015-03-27 | Boehringer Ingelheim Int | Anti-il-23 antibodies |
| JOP20140049B1 (ar) | 2013-03-08 | 2021-08-17 | Lilly Co Eli | أجسام مضادة ترتبط بـ il-23 |
| US20170002060A1 (en) * | 2014-01-08 | 2017-01-05 | Moderna Therapeutics, Inc. | Polynucleotides for the in vivo production of antibodies |
| EP3762015A4 (fr) * | 2018-03-05 | 2022-04-27 | Janssen Biotech, Inc. | Méthodes de traitement de la maladie de crohn avec un anticorps spécifique anti-il23 |
-
2019
- 2019-03-27 TW TW108110767A patent/TWI744617B/zh active
- 2019-03-28 MX MX2020010269A patent/MX2020010269A/es unknown
- 2019-03-28 KR KR1020207027982A patent/KR102552693B1/ko active IP Right Grant
- 2019-03-28 SG SG11202009526RA patent/SG11202009526RA/en unknown
- 2019-03-28 EA EA202091989A patent/EA202091989A1/ru unknown
- 2019-03-28 DK DK19722256.5T patent/DK3773715T3/da active
- 2019-03-28 MA MA052216A patent/MA52216A/fr unknown
- 2019-03-28 US US16/981,915 patent/US20210032325A1/en active Pending
- 2019-03-28 BR BR112020018099-8A patent/BR112020018099A2/pt unknown
- 2019-03-28 LT LTEPPCT/US2019/024633T patent/LT3773715T/lt unknown
- 2019-03-28 FI FIEP19722256.5T patent/FI3773715T3/fi active
- 2019-03-28 EP EP23215626.5A patent/EP4327866A3/fr active Pending
- 2019-03-28 CN CN201980023563.3A patent/CN111936165A/zh active Pending
- 2019-03-28 WO PCT/US2019/024633 patent/WO2019191464A1/fr active Application Filing
- 2019-03-28 JP JP2020552872A patent/JP7119114B2/ja active Active
- 2019-03-28 EP EP19722256.5A patent/EP3773715B1/fr active Active
- 2019-03-28 AU AU2019243283A patent/AU2019243283C1/en active Active
- 2019-03-28 PT PT197222565T patent/PT3773715T/pt unknown
- 2019-03-28 CA CA3095297A patent/CA3095297A1/fr active Pending
-
2020
- 2020-09-22 IL IL277514A patent/IL277514A/en unknown
-
2022
- 2022-08-03 JP JP2022123689A patent/JP7331219B2/ja active Active
-
2023
- 2023-08-09 JP JP2023130117A patent/JP2023166388A/ja active Pending
- 2023-10-11 AU AU2023248103A patent/AU2023248103A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019243283C1 (en) | 2024-05-02 |
| KR102552693B1 (ko) | 2023-07-07 |
| CA3095297A1 (fr) | 2019-10-03 |
| TW202206104A (zh) | 2022-02-16 |
| KR20200128101A (ko) | 2020-11-11 |
| IL277514A (en) | 2020-11-30 |
| TW201946657A (zh) | 2019-12-16 |
| TWI744617B (zh) | 2021-11-01 |
| EP4327866A3 (fr) | 2024-03-20 |
| EA202091989A1 (ru) | 2021-01-13 |
| AU2019243283B2 (en) | 2023-07-27 |
| JP7331219B2 (ja) | 2023-08-22 |
| BR112020018099A2 (pt) | 2020-12-22 |
| AU2023248103A1 (en) | 2023-11-09 |
| EP4327866A2 (fr) | 2024-02-28 |
| JP2021517156A (ja) | 2021-07-15 |
| FI3773715T3 (fi) | 2024-05-30 |
| SG11202009526RA (en) | 2020-10-29 |
| WO2019191464A1 (fr) | 2019-10-03 |
| LT3773715T (lt) | 2024-06-25 |
| EP3773715B1 (fr) | 2024-05-08 |
| AU2019243283A1 (en) | 2020-09-24 |
| JP7119114B2 (ja) | 2022-08-16 |
| PT3773715T (pt) | 2024-05-27 |
| JP2023166388A (ja) | 2023-11-21 |
| EP3773715A1 (fr) | 2021-02-17 |
| CN111936165A (zh) | 2020-11-13 |
| JP2022169562A (ja) | 2022-11-09 |
| MX2020010269A (es) | 2020-11-06 |
| US20210032325A1 (en) | 2021-02-04 |
| MA52216A (fr) | 2021-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3773715T3 (da) | Mirikizumab i behandlingen af colitis ulcerosa | |
| DK3578547T3 (da) | Sulfonylureaer og relaterede forbindelser og brug af samme | |
| DK3554631T3 (da) | Behandling af patienter med ttfields med elektrodepositionerne optimeret under anvendelse af deformerbare skabeloner | |
| DK3743053T3 (da) | Anvendelse af cannabinoider i behandling af epilepsi | |
| DK3512850T3 (da) | Inhibitorer af menin-mll-interaktionen | |
| DK3468966T3 (da) | Inhibitorer af menin-mll-interaktionen | |
| DK3334422T3 (da) | Anvendelse af cannabidiolsyre i behandling af epilepsi | |
| DK3117310T3 (da) | Håndtering af behandling associeret med valgte arkitektoniske indretninger | |
| DK3641819T3 (da) | Anvendelse af cannabidiol i behandling af tuberøst sklerosekompleks | |
| DK3576738T3 (da) | Gaboxadolmonohydrat i behandling af tinnitus | |
| DK3701973T3 (da) | Plasmabaseret film og fremgangsmåder til fremstilling og anvendelse af samme | |
| DK3562486T3 (da) | Anvendelse af sublingual dexmedetomidin til behandling af agitation | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3204497T3 (da) | Terapeutisk hæmning af lactatdehydrogenase og midler dertil | |
| DK3638696T3 (da) | Anvendelse af anti-cd70-antistof argx-110 til behandling af akut myeloid leukæmi | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| DK3464368T3 (da) | Anvendelse af et anti-pd-1-antistof i kombination med et anti-cd30- antistof i lymfombehandling | |
| DK3273995T3 (da) | Kombineret anvendelse af alginatoligomerer og cftr-modulatoren lumacaftor i behandlingen af tilstande associeret med cftr-dysfunktion | |
| DK3506904T3 (da) | Behandling af demens | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3501268T3 (da) | Regenerering af planter i tilstedeværelse af histondeacetylase hæmmere | |
| DK3368044T3 (da) | Behandling af hepatisk steatose-relateret oligo-ovulation | |
| DK3506901T3 (da) | Anvendelse af kynurensyre til behandling af muskelatrofi | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi |